Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Bovie Medical Corp (BVX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [AMEX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [AMEX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart

Fundamentals

See More
  • Market Capitalization, $K 63,263
  • Shares Outstanding, K 30,860
  • Annual Sales, $ 36,630 K
  • Annual Income, $ -3,950 K
  • 36-Month Beta -0.46
  • Price/Sales 1.67
  • Price/Cash Flow 0.00
  • Price/Book 2.47

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.87 +9.63%
on 05/16/17
2.83 -27.56%
on 05/12/17
-0.64 (-23.79%)
since 04/26/17
3-Month
1.87 +9.63%
on 05/16/17
3.46 -40.75%
on 02/27/17
-1.22 (-37.31%)
since 02/24/17
52-Week
1.58 +29.75%
on 06/01/16
5.75 -64.35%
on 10/31/16
+0.44 (+27.33%)
since 05/26/16

Most Recent Stories

More News
Bovie Medical Corporation Reports First Quarter 2017 Financial Results and Introduces Fiscal Year 2017 Financial Outlook

Bovie Medical Corporation (NYSEMKT:BVX) (the "Company"), a maker of medical devices and supplies and the developer of J-Plasma(R), a patented new surgical product, today reported financial...

BVX : 2.05 (+3.54%)
Bovie Medical Corporation to Release First Quarter 2017 Financial Results on May 15, 2017

Bovie Medical (NYSE MKT: BVX), a maker of medical devices and supplies and the developer of J-Plasma(R), a patented new surgical product, today announced that financial results for the first...

BVX : 2.05 (+3.54%)
Align Partners Zfx GmbH to Expand iTero Scanner Business

Align Technology Inc. (ALGN) announced a non-exclusive agreement with digital prosthetic solutions maker, Zfx GmbH on iTero Element intraoral scanners.

BVX : 2.05 (+3.54%)
RMD : 70.07 (+0.03%)
ALGN : 142.10 (+0.50%)
INGN : 87.93 (-1.15%)
VWR Corp Acquires EPL Archives, Improves Customer Service

VWR Corporation (VWR) recently acquired the international biorepository services organization, EPL Archives, Inc.

VWR : 32.87 (-0.06%)
BVX : 2.05 (+3.54%)
RMD : 70.07 (+0.03%)
INGN : 87.93 (-1.15%)
Bovie Medical Receives 510K Clearance for Its Cool-Coag(TM) Generator and Open Handpiece

--Commercial Launch Scheduled in Second Half of 2017

BVX : 2.05 (+3.54%)
PetMed Express' New Order Sales Disappoint, Competition Rife

On Mar 23, we issued an updated research report on Pompano Beach, FL-based PetMed Express, Inc. (PETS).

PETS : 34.46 (-0.20%)
BVX : 2.05 (+3.54%)
RMD : 70.07 (+0.03%)
INGN : 87.93 (-1.15%)
Walgreen Boots Buyout of Rite Aid Delayed, Other Woes Remain

On Mar 24, we issued an updated research report on Illinois-based leading pharmacy-led, health and wellbeing enterprise, Walgreens Boots Alliance, Inc. (WBA).

BVX : 2.05 (+3.54%)
WBA : 81.25 (+0.62%)
RMD : 70.07 (+0.03%)
INGN : 87.93 (-1.15%)
Medtronic's (MDT) CoreValve Evolut Pro Receives FDA Approval

Medical device major Medtronic plc (MDT) recently announced that it has received the FDA approval for its CoreValve Evolut PRO valve.

BVX : 2.05 (+3.54%)
RMD : 70.07 (+0.03%)
MDT : 85.09 (-0.57%)
INGN : 87.93 (-1.15%)
Hologic Completes Cynosure Buyout, Boosts Core Business

Hologic, Inc. (HOLX) recently announced the completion of it earlier declared acquisition of marketer of aesthetic treatment systems, Cynosure, Inc.

HOLX : 43.35 (-0.34%)
BVX : 2.05 (+3.54%)
RMD : 70.07 (+0.03%)
INGN : 87.93 (-1.15%)
MedTech Long-Term Prospects Impress: Which Stocks to Buy?

MedTech Long-Term Prospects Impress: Which Stocks to Buy?

CERN : 64.95 (-0.23%)
BVX : 2.05 (+3.54%)
VAR : 97.87 (+0.15%)
JNJ : 126.92 (-0.48%)
ALR : 48.82 (-0.08%)
MASI : 87.44 (-0.18%)
WMGI : 27.05 (-1.39%)
SNN : 34.89 (-0.37%)
CYH : 9.36 (-1.47%)
ABT : 44.71 (+1.73%)
MDT : 85.09 (-0.57%)
QDEL : 24.91 (-0.04%)
ZBH : 119.23 (-0.06%)
OFIX : 42.51 (unch)
OSUR : 14.84 (+0.27%)
BSX : 27.32 (+0.22%)
TFX : 201.21 (-0.06%)
RMD : 70.07 (+0.03%)
CYNO : 66.15 (+0.23%)
BIO : 220.98 (-0.19%)
INGN : 87.93 (-1.15%)
PKI : 62.80 (unch)
HOLX : 43.35 (-0.34%)
EW : 114.25 (+0.07%)
TMO : 173.42 (+0.30%)
MDRX : 11.38 (-0.96%)
IDXX : 167.56 (+0.10%)
BAX : 58.64 (-0.85%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Maximum. Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More

Business Summary

Bovie Medical Corporation, formerly An-Con Genetics Inc., is engaged in the manufacturing and marketing of a diverse line of medical devicesand advanced coating technologies.

See More

Support & Resistance

2nd Resistance Point 2.12
1st Resistance Point 2.08
Last Price 2.05
1st Support Level 1.98
2nd Support Level 1.92

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.